Magnetar Financial’s Kyntra Bio KYNB Stock Holding History

Magnetar Financial’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-634	Closed	-$588K	–	1093
2020 Q4	$588K	Buy	+634	New	+$666K	0.01%	539

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Magnetar Financial's KYNB Position: Q1 2021 in Review

Magnetar Financial sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 634 shares — an estimated $588K sold.

Magnetar Financial first reported a position in KYNB in Q4 2020 and held it in 1 quarter. The position peaked at $588K in Q4 2020. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

Magnetar Financial reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
Magnetar Financial sold 634 Kyntra Bio shares in Q1 2021, an estimated $588K.
Magnetar Financial first reported a position in Kyntra Bio in Q4 2020 and held it in 1 quarter.
Magnetar Financial's Kyntra Bio position peaked at $588K in Q4 2020.
198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Magnetar Financial's 13F filing for Q1 2021, filed 14 May 2021.